Sancho-Saldaña, A.; Gil Sánchez, A.; Quirant-Sánchez, B.; Nogueras, L.; Peralta, S.; Solana, M.J.; González-Mingot, C.; Gallego, Y.; Quibus, L.; Ramo-Tello, C.;
et al. Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies. J. Clin. Med. 2022, 11, 2509.
https://doi.org/10.3390/jcm11092509
AMA Style
Sancho-Saldaña A, Gil Sánchez A, Quirant-Sánchez B, Nogueras L, Peralta S, Solana MJ, González-Mingot C, Gallego Y, Quibus L, Ramo-Tello C,
et al. Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies. Journal of Clinical Medicine. 2022; 11(9):2509.
https://doi.org/10.3390/jcm11092509
Chicago/Turabian Style
Sancho-Saldaña, AgustÃn, Anna Gil Sánchez, Bibiana Quirant-Sánchez, Lara Nogueras, Silvia Peralta, Maria José Solana, Cristina González-Mingot, Yhovanni Gallego, Laura Quibus, Cristina Ramo-Tello,
and et al. 2022. "Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies" Journal of Clinical Medicine 11, no. 9: 2509.
https://doi.org/10.3390/jcm11092509
APA Style
Sancho-Saldaña, A., Gil Sánchez, A., Quirant-Sánchez, B., Nogueras, L., Peralta, S., Solana, M. J., González-Mingot, C., Gallego, Y., Quibus, L., Ramo-Tello, C., Presas-RodrÃguez, S., MartÃnez-Cáceres, E., Torres, P., Hervás, J. V., Valls, J., & Brieva, L.
(2022). Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies. Journal of Clinical Medicine, 11(9), 2509.
https://doi.org/10.3390/jcm11092509
